Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,851 | -7,022 | -4,801 | -2,655 | -8,394 |
| Depreciation Amortization | 122 | 90 | 59 | 28 | 106 |
| Accounts receivable | 698 | 617 | 170 | -85 | -323 |
| Other Working Capital | 102 | -629 | -344 | -142 | 460 |
| Other Operating Activity | -344 | -342 | 16 | 183 | 595 |
| Operating Cash Flow | $-9,273 | $-7,285 | $-4,900 | $-2,671 | $-7,556 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | -4 |
| Purchase Of Investment | -597 | -458 | -351 | -146 | -618 |
| Sale Of Investment | 620 | 475 | 365 | 140 | 620 |
| Investing Cash Flow | $20 | $17 | $14 | $-6 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 245 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 245 | 245 | N/A | N/A |
| Common Stock Issued | 8,659 | 8,663 | 2,130 | 2,130 | N/A |
| Other Financing Activity | 1,693 | 1,691 | 1,691 | 0 | 97 |
| Financing Cash Flow | $10,597 | $10,598 | $4,065 | $2,130 | $97 |
| Beginning Cash Position | 4,906 | 4,906 | 4,906 | 4,906 | 12,367 |
| End Cash Position | 6,250 | 8,236 | 4,085 | 4,359 | 4,906 |
| Net Cash Flow | $1,344 | $3,330 | $-821 | $-547 | $-7,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,273 | -7,285 | -4,900 | -2,671 | -7,556 |
| Capital Expenditure | -4 | N/A | N/A | N/A | -4 |
| Free Cash Flow | -9,276 | -7,285 | -4,900 | -2,671 | -7,560 |